Alere (ALR) – StreetInsider.com Reports
-
ABP Acquisition to Acquire AlerisLife (ALR) for $1.31 Per Share
-
Alere (ALR) Halted, News Pending
-
Alere (ALR) PT Lowered to $1.50 at B.Riley
-
Alere (ALR) Misses Q3 EPS by 10c
-
Alere (ALR) Appoints Philip Benjamson as COO
-
Alere (ALR) PT Raised to $2 at B.Riley
-
Alere (ALR) Issues Business Update
-
B.Riley Downgrades Alere (ALR) to Neutral
-
Alere (ALR) Misses Q1 EPS by 20c
-
Alere (ALR) Misses Q4 EPS by 34c
-
Benchmark Starts Alere (ALR) at Buy
-
Alere (ALR) Announces FDA Clearance for Alere i Influenza A & B 2 Rapid Molecular Test
-
Alere (ALR) Reports U.S. DOJ has Ended Investigation Into Sales, Sales Practices and Dealings with Certain 3rd Parties
-
Abbott (ABT) Se to Close Alere (ALR) Takeover on October 3
-
Alere (ALR) Announces Agreement in Principle to Settle with U.S. Department of Justice
-
Abbott (ABT) Wins Canadian Approval for Alere (ALR) Takeover - Bloomberg
-
Abbott (ABT) Expects Outstanding Alere (ALR) Buy Approvals Soon - Bloomberg, Citing Email
-
Quidel (QDEL) Announces Early Termination of HSR Waiting Period for Pending Acquisition of Alere's (ALR) Triage BNP Assay Business Run on Beckman Coulter Analyzers
-
Parties Confident EC Will Ok Alere (ALR)/Abbott (ABT) by Sept 30- Bloomberg, Citing DealReporter
-
FTC requires Abbott (ABT) divestments for Alere (ALR) purchase
-
Alere (ALR) Active, Shares Gain
-
Alere (ALR) Reports Settlement with SEC, to Pay $13M
-
S&P ekes out record on healthcare gains, tax plan hopes
-
Alere (ALR) Dips to Session Low
-
Quidel Corp (QDEL) Gains After Revised Deal on Alere's (ALR) BNP Assay Business
-
Alere (ALR) Trades at Lows
-
UPDATE: Alere (ALR) Lower on Negative Mention by Reorg's Event-Driven Report - Bloomberg
-
Alere (ALR) Active, Shares Decline
-
Einhorn's Greenlight Capital Enters Hewlett Packard Enterprise (HPE), Adds to Micron (MU), More...
-
Alere (ALR) Says Immunalysis Receives FDA Clearance for SEFRIA Fentanyl Urine Drug Screening Test
-
Alere (ALR)/Abbott (ABT) is Said Likely to Win Korean Approval - Bloomberg, Citing MLex
-
Alere (ALR) Shareholders Approve Amended Merger with Abott (ABT)
-
Alere (ALR) Reports Q1 GAAP Loss of $0.80/Share
-
Canaccord Genuity Downgrades Alere (ALR) to Hold
-
Alere (ALR) Files Form 10-K
-
Alere (ALR) Offers Prelim. Q1 Results and Update on Form 10-K
-
Einhorn's Greenlight Capital Confirms Perrigo (PRGO) Stake, Adds Varex Imaging (VREX), Back in Micron (MU)
-
Eton Park's 13F Shows Increase in Comcast (CMCSA), Decrease in Bank of America (BAC), Liquidated Google (GOOGL) (More...)
-
Alere's (ALR) Deal with Abbott (ABT) Still Likely to Close at Stated Terms, Says BTIG
-
Options with increasing unusual call volume: SCSS IDRA ALR WUBA SAGE FFIV
-
Pre-Open Movers 04/17: (CBLI) (ALR) (STRP) Higher; (OMED) (LNCE) (INCY) Lower (more...)
-
Alere (ALR) PT Lowered to $51 at Canaccord Genuity
-
Alere (ALR) PT Lowered to $51 at Jefferies Following Announced Revisions to ABT Merger
-
Alere (ALR) volatility flat into Abbott Laboratories (ABT) agreeing to buy at $51 per share rather than previous offer of $56
-
Abbott (ABT) to Acquire Alere (ALR) for $51/Share in Amended Agreement
-
Alere (ALR) volatility flat into Abbott Laboratories (ABT) agreeing to buy at $51 per share rather than previous offer of $56
-
Alere (ALR) Reports FDA 510(K) Clearance for Alere Reader Platform
-
UPDATE: Alere (ALR) Climbs Amid Circulation of Court Filing in Abbott (ABT) Case - Bloomberg
-
Alere (ALR) April volatility increases to 72 into Q4 and outlook
-
Abbott (ABT) Says Mylan (MYL) Sale Unrelated to Alere (ALR) - Bloomberg
Back to ALR Stock Lookup